Atomwise
Revolutionizing drug discovery through advanced AI technology and massive chemical libraries at Atomwise.
Atomwise is a pioneering artificial intelligence (AI) company in drug discovery, using advanced AI to transform the way new medicines are developed, focusing on challenging problems in small molecule drug discovery. Their mission is to create better medicines faster and more cost-effectively through their machine learning-based engine, combining neural networks with vast chemical libraries. The team's expertise and prominent investor backing support their commitment to reinventing drug discovery with AI.
About Atomwise
Atomwise is a pioneering company in the field of artificial intelligence (AI) for drug discovery. They utilize their advanced AI engine to transform the way new medicines are developed, focusing on the most challenging problems in small molecule drug discovery. The company's mission is to create better medicines faster and more cost-effectively than traditional methods.
Atomwise's portfolio includes both wholly owned pipeline assets and co-developed projects, all backed by prominent investors. Their leading technology development and application involves a machine learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small molecule medicines.
Their commitment to reinventing drug discovery with AI is grounded in their team's expertise. They are dedicated to developing the best AI platform and using it to transform small molecule drug discovery.
